Early Phase 1 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged between 18 and 75 years, either male or female.
- People with multiple spots on the lungs (seen on scans) that have been present for more than one year, assessed by a team of senior radiology, surgery, and cancer specialists as likely being multiple lung cancers, and where the person has decided against continued monitoring.
- People who have previously had surgery confirming a type of lung cancer called non-small cell lung cancer (NSCLC), and whose scans during follow-up or after targeted treatment now show the cancer has grown or new spots have appeared, assessed by a specialist team as lung cancer, and where the person has decided against surgery or other treatments.
- People from whom a small tumour sample (approximately 1–1.5 cm³) can be collected through surgery, biopsy, or bronchoscopy to prepare a personalised immune cell treatment.
- People with a general health and activity level rated 0–2 on a standard medical scale (meaning able to carry out daily activities, with at most some limitations) (confirm with trial site).
- People with a haemoglobin (red blood cell) level of at least 70 g/L, and who are able to receive a blood transfusion if needed.
- People with no serious liver, kidney, heart, or lung problems, specifically meeting all of the following: kidney function within an acceptable range; blood oxygen level above 90%; liver function markers within acceptable ranges.
- People expected to survive more than 5 years, with complete and documented medical records.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose lung cancer has been confirmed by testing to contain small cell lung cancer cells.
- People whose suspicious lung spots have been present for less than six months, or where the spots went away after anti-inflammatory treatment.
- People who have previously received an organ transplant from another person, or who have had treatments to reduce the immune system including lymph node removal.
- People who are currently taking steroid medications.
- People who have a serious or ongoing infection that has not been brought under control with treatment.
- People who have a serious autoimmune disease or an inherited immune system condition.
- People with a history of severe allergic reactions to biological products, including antibiotics.
- People with active hepatitis B or hepatitis C infection detected through blood testing.
- People who have HIV or syphilis infection.
- Women who are pregnant, breastfeeding, or planning to become pregnant within 12 months.
- People who, in the opinion of the trial investigators, have conditions that could increase their risk or affect the trial results.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
According to the incidence of treatment-related adverse events（AEs）to evaluate the safety of Tumor-Infiltrating Lymphocytes (TILs) therapy for multiple primary early-stage Non-Small Cell Lung Cancer （NSCLC）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.